HOME >> BIOLOGY >> NEWS
Drug that cuts off tumor's blood supply extends lives of colorectal cancer patients

A drug designed to cut off a tumor's blood supply, when paired with a chemotherapy combination, resulted in significant improvement in survival in patients with metastatic colorectal cancer, the first time in decades that survival times have been extended in patients with this devastating form of advanced cancer.

The results of the study, done at UCLA's Jonsson Cancer Center and several other sites nationwide, appear June 3, 2004 in the New England Journal of Medicine.

The study paired the angiogenesis inhibitor Avastin, approved by the U.S. Food and Drug Administration in February for use in colorectal cancer, with irinotecan, 5-fluorouracil and leucovorin. The combination therapy improved median survival in patients by nearly five months, reducing risk of death by more than 30 percent. It also improved response rates, duration of response and progression-free survival times, said Dr. Fairooz Kabbinavar, a Jonsson Cancer Center researcher and senior author of the study.

"To put this study in the right perspective, up until the year 2000, median survival in patients with advanced colorectal cancer was about 12 months," said Kabbinavar, an associate professor of hematology/oncology who has been working with Avastin for the last 10 to 12 years, both in the lab and in the clinic. "In just four short years, we're now looking at survivals in excess of two years. We've come a long way. Avastin has not only changed the way we treat colorectal cancer, but I believe it will become a part of cancer management for other tumors such as lung, breast and pancreatic cancers."

A tumor cannot grow bigger than a pinhead unless it establishes an independent blood supply through a process called angiogenesis. This process provides the tumor with the oxygen and nutrients it needs to grow and spread. Researchers have theorized that by stopping or cutting off the new blood supply, they can starve and, hopefully, kill the cancer. Researchers had hoped that
'"/>

Contact: Kim Irwin
kirwin@mednet.ucla.edu
310-206-2805
University of California - Los Angeles
2-Jun-2004


Page: 1 2 3

Related biology news :

1. Scientists discover gene signature for tumors tendency to spread
2. Experimental drug shown to block mutant protein causing blood disease
3. IBD (Crohns, Colitis) joins cancer, inflammatory diseases in associated blood vessel growth
4. A probable cause for high blood pressure identified - shows links with diabetes
5. Probing the surface of white blood cells to enhance immune system medicine
6. Streptococcus infects humans by thwarting blood clotting
7. Strep disrupts blood clotting to infect humans
8. Nucleic acid-amplification testing further safeguards nations blood supply
9. Hopkins scientists use blood proteins to detect ovarian cancer
10. Marijuana ingredient inhibits VEGF pathway required for brain tumor blood vessels
11. Oxygen sensing in worms may hold key to healthy blood pressure in humans

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/11/2020)... ... March 11, 2020 , ... USARAD ... by Siemens Healthineers and several healthcare VC firms introduces a first of its ... over 100 countries and has caused over 4,000 fatalities to date. Over the ...
(Date:3/5/2020)... SAN DIEGO (PRWEB) , ... March 05, 2020 ... ... Inc. today announced a strategic partnership agreement with Phoenestra GmbH to accelerate Cytonus’ ... biotech company founded in San Diego, California. Phoenestra is a biotech company located ...
(Date:3/5/2020)... ... March 05, 2020 , ... ... Test™ technology . The AlphaSTEM Test™ is the first, and still only, ... Other technologies that attempt to provide information about the number and quality ...
Breaking Biology News(10 mins):
(Date:2/11/2020)... ... February 11, 2020 , ... ... solutions services in North America, today announced that the City of Fort Worth ... its biosolids management needs. Commencing in April of 2020, Synagro will assume operation ...
(Date:2/5/2020)... , ... February 04, 2020 , ... ... for characterizing microbiome populations down to the strain level, has announced a new ... Shoreline Biome’s microbiome kits and other products to companies and research organizations in ...
(Date:2/3/2020)... ... February 03, 2020 , ... Ovation Travel Group ... Travel, Technology Industry Travel and Biotech/Healthcare Industry Travel Indexes. , All of the ... following statistics:, Average airfare price paid Domestically, Internationally ...
(Date:1/28/2020)... ... January 28, 2020 , ... Lifecycle ... to food and beverage manufactures within North America. Both Lifecycle and Midland have ... will allow each company to pool their collective resources and provide the industry ...
Breaking Biology Technology:
Cached News: